NK cells, by secreting tumor necrosis factor (TNF) and interferon (IFN), kill susceptible target cellsthereby exerting the cytolytic activity and improving the prognosis of patients with glioma [43]. The gene discussed is IFNA1; the disease is central nervous system cancer.